Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Totals |
||
Shortage reports |
111 |
|
| Actual shortage: | 2 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (5%) | |
| Resolved: | 104 (94%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 8 (89%) | |
| Reversed: | 1 (11%) | |
Late reports |
3 (3%) |
|
Overdue reports |
2 (100%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VIIBRYD | 10MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72344 |
| VIIBRYD | 10MG | TABLET | Resolved | 2019-02-28 | 2019-05-14 | 77159 |
| VIIBRYD | 10MG | TABLET | Resolved | 2022-12-19 | 2023-02-09 | 178808 |
| VIIBRYD | 10MG | TABLET | Resolved | 2023-05-15 | 2023-06-09 | 192501 |
| VIIBRYD | 10MG | TABLET | Resolved | 2023-12-07 | 2024-01-16 | 212766 |
| LUPRON DEPOT | 11.25MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Resolved | 2019-11-23 | 2019-12-07 | 99582 |
| LUPRON DEPOT | 11.25MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Resolved | 2020-06-25 | 2021-03-08 | 118920 |
| FETZIMA | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-21 | 2023-08-16 | 199542 |
| CONSTELLA | 145MCG | CAPSULE | Resolved | 2019-05-25 | 2019-06-11 | 84767 |
| SALOFALK | 1G | SUPPOSITORY | Resolved | 2022-05-25 | 2022-06-07 | 161258 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-27 | 163730 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-12-09 | 2023-01-19 | 177700 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2023-10-11 | 2023-11-23 | 206797 |
| BYSTOLIC | 20.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84755 |
| BYSTOLIC | 20MG | TABLET | Resolved | 2022-01-20 | 2022-09-01 | 153204 |
| FETZIMA | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-05-25 | 2019-06-07 | 84776 |
| VIIBRYD | 20MG | TABLET | Resolved | 2019-01-15 | 2019-05-09 | 72342 |
| VIIBRYD | 20MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84782 |
| VIIBRYD | 20MG | TABLET | Resolved | 2022-12-19 | 2023-01-27 | 178811 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
| TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
| MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
| MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
| HUMIRA | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
| HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
| LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
| MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
| NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
Showing 1 to 9 of 9